PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auction

The bankrupt gene editing biotech Sangamo is set to sell chunks of its business to PTC Therapeutics and Eli Lilly for up to $264 million following an auction procedure. Sangamo said ...